Welcome to Fate Therapeutics Third Quarter 2017 Financial Results Conference Call. [Operator Instructions]. I would now like to introduce Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.
FATE Fate Therapeutics
|Scott Wolchko||President and CEO|
|Chris Storgard||Chief Medical Officer|
|Dan Shoemaker||Chief Scientific Officer|
|David Nierengarten||Wedbush Securities|
|Do Kim||BMO Capital Markets|
|ED White||H.C. Wainwright|
Thank you. Good afternoon and thanks everyone for joining us for the Fate Therapeutics third quarter 2017 financial results call.